Microbix Biosystems (MBXBF) 0.2258 $MBXBF
Microbix Revenue Grows 7% in Second Quarter
Marketwire Canada - Mon May 16, 6:01AM CDT
Company provides corporate updates
MBX.TO: 0.27 (-0.02)
Microbix Announces Annual and Special Meeting Voting Results
Marketwired - Thu Apr 07, 2:01PM CDT
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"
, an innovator of biological products and technologies, announces the results of the Annual and Special Meeting of Shareholders that was held on April 6, 2016, at which 45.98% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in the Company's Information Circular, which was filed on SEDAR on March 7, 2016. All of the director nominees listed in the Information Circular were re-elected as directors of Microbix. Detailed results of the vote are set out below:
MBX.TO: 0.27 (-0.02)
Microbix Announces New Product Development Program to Help Combat Zika Virus
Marketwired - Fri Feb 05, 6:45AM CST
Microbix Biosystems Inc. (TSX: MBX) (the Company), an innovator of biological products and technologies, today announced plans to develop and introduce new products for use in diagnostic tests and vaccine research in response to the emergent Zika virus, which is spreading throughout the Americas and is being characterized as a crisis by health authorities.
MBX.TO: 0.27 (-0.02)
Microbix Reports Fiscal 2015 Results Continued Profitability and Revenue Growth
Marketwired - Thu Dec 31, 5:32PM CST
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial results for its fourth quarter and fiscal year ending September 30, 2015 and corporate updates about its operations.
MBX.TO: 0.27 (-0.02)
Microbix Announces Delay in Filing of Annual Financial Statements
Marketwired - Wed Dec 30, 4:01PM CST
Microbix Biosystems Inc. (TSX: MBX) announces that it has not filed its required filings by the prescribed deadline of December 29, 2015. These required filings consist of its audited annual financial statements, management discussion and analysis and its annual information form, all for the fiscal year ended September 30, 2015.
MBX.TO: 0.27 (-0.02)
Microbix Revenue for First Nine Months Grows 12%
Marketwired - Fri Aug 14, 6:30AM CDT
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its third quarter ending June 30, 2015.
MBX.TO: 0.27 (-0.02)
Microbix Revenue Grows 7% in Second Quarter
Marketwire Canada - Mon May 16, 6:01AM CDT
Company provides corporate updates
MBX.TO: 0.27 (-0.02)
Microbix Announces Annual and Special Meeting Voting Results
Marketwired - Thu Apr 07, 2:01PM CDT
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"
, an innovator of biological products and technologies, announces the results of the Annual and Special Meeting of Shareholders that was held on April 6, 2016, at which 45.98% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in the Company's Information Circular, which was filed on SEDAR on March 7, 2016. All of the director nominees listed in the Information Circular were re-elected as directors of Microbix. Detailed results of the vote are set out below: MBX.TO: 0.27 (-0.02)
Microbix Announces New Product Development Program to Help Combat Zika Virus
Marketwired - Fri Feb 05, 6:45AM CST
Microbix Biosystems Inc. (TSX: MBX) (the Company), an innovator of biological products and technologies, today announced plans to develop and introduce new products for use in diagnostic tests and vaccine research in response to the emergent Zika virus, which is spreading throughout the Americas and is being characterized as a crisis by health authorities.
MBX.TO: 0.27 (-0.02)
Microbix Reports Fiscal 2015 Results Continued Profitability and Revenue Growth
Marketwired - Thu Dec 31, 5:32PM CST
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial results for its fourth quarter and fiscal year ending September 30, 2015 and corporate updates about its operations.
MBX.TO: 0.27 (-0.02)
Microbix Announces Delay in Filing of Annual Financial Statements
Marketwired - Wed Dec 30, 4:01PM CST
Microbix Biosystems Inc. (TSX: MBX) announces that it has not filed its required filings by the prescribed deadline of December 29, 2015. These required filings consist of its audited annual financial statements, management discussion and analysis and its annual information form, all for the fiscal year ended September 30, 2015.
MBX.TO: 0.27 (-0.02)
Microbix Revenue for First Nine Months Grows 12%
Marketwired - Fri Aug 14, 6:30AM CDT
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its third quarter ending June 30, 2015.
MBX.TO: 0.27 (-0.02)
